Table 1 Characteristics of... | American Society of Hematology

Table 1

Characteristics of HIV-1–infected patients analyzed in this study

Patient	Sex/age, y	HIV-1⁺, y*	HIV-RNA,† copies/mL	Stage‡	No. CD4,§ cells/mL	No. CD8,§ cells/mL	CD4/CD8 ratio
1	M/54	2004	16000	A2	387	895	0.4
2	F/48	2003	57000	A2	226	800	0.3
3	F/53	2003	4200	A1	616	648	1.0
4	F/42	2003	10000	A2	381	820	0.6
5	M/30	2003	6600	A1	500	737	0.7
6	M35	2004	900	B1	539	1081	0.5
7	F/49	2004	6700	A2	247	804	0.3
8	F/23	2004	1800	A2	412	754	0.5
9	F/28	2004	24000	A2	338	708	0.5
10	M/40	2003	27000	B1	539	2815	0.2
11	M/30	2003	6300	A1	911	915	1.0
12	F/26	2003	12000	A1	583	470	1.2
13	F/29	2004	< 80	A1	543	4069	0.1
14	M/37	2004	18000	A2	292	681	0.4
15	M/32	2003	1500	A2	251	756	0.3
16	M/36	2003	< 80	A2	314	709	0.4
17	F/31	2003	61000	B2	455	919	0.5
18	F/31	2004	11000	A2	265	1267	0.2
19	M/31	2003	3000	A2	248	537	0.5
20	M/41	2004	35000	A2	314	480	0.6
21	M/42	2003	21000	A1	640	1340	0.4
22	F/22	2004	< 80	A1	694	878	0.8
23	F/28	2003	1980	A1	688	517	1.3
24	M/32	2003	17000	A1	635	695	0.9
25	F/43	2003	< 80	A2	287	351	0.8
26	M/41	2004	< 80	A2	266	1271	0.2
27	M/38	2003	16000	A2	509	1040	0.5
28	F/21	2003	1100	A2	446	400	1.1
29	M/37	2004	38000	A2	220	1009	0.2
30	M/39	2003	22500	B2	365	925	0.4

Patient	Sex/age, y	HIV-1⁺, y*	HIV-RNA,† copies/mL	Stage‡	No. CD4,§ cells/mL	No. CD8,§ cells/mL	CD4/CD8 ratio
1	M/54	2004	16000	A2	387	895	0.4
2	F/48	2003	57000	A2	226	800	0.3
3	F/53	2003	4200	A1	616	648	1.0
4	F/42	2003	10000	A2	381	820	0.6
5	M/30	2003	6600	A1	500	737	0.7
6	M35	2004	900	B1	539	1081	0.5
7	F/49	2004	6700	A2	247	804	0.3
8	F/23	2004	1800	A2	412	754	0.5
9	F/28	2004	24000	A2	338	708	0.5
10	M/40	2003	27000	B1	539	2815	0.2
11	M/30	2003	6300	A1	911	915	1.0
12	F/26	2003	12000	A1	583	470	1.2
13	F/29	2004	< 80	A1	543	4069	0.1
14	M/37	2004	18000	A2	292	681	0.4
15	M/32	2003	1500	A2	251	756	0.3
16	M/36	2003	< 80	A2	314	709	0.4
17	F/31	2003	61000	B2	455	919	0.5
18	F/31	2004	11000	A2	265	1267	0.2
19	M/31	2003	3000	A2	248	537	0.5
20	M/41	2004	35000	A2	314	480	0.6
21	M/42	2003	21000	A1	640	1340	0.4
22	F/22	2004	< 80	A1	694	878	0.8
23	F/28	2003	1980	A1	688	517	1.3
24	M/32	2003	17000	A1	635	695	0.9
25	F/43	2003	< 80	A2	287	351	0.8
26	M/41	2004	< 80	A2	266	1271	0.2
27	M/38	2003	16000	A2	509	1040	0.5
28	F/21	2003	1100	A2	446	400	1.1
29	M/37	2004	38000	A2	220	1009	0.2
30	M/39	2003	22500	B2	365	925	0.4

Year of diagnosis.

†

HIV-1 RNA was quantitated using the commercial branched DNA (bDNA Ultrasensitive Assay; Chiron) with a lower limit of detection of 50 RNA copies/mL.

‡

Stage was defined according to the CDC criteria. Patients 1, 2, 6, 9, and 30 have a clinical history of oral candidosis. Patients showed stable disease in 2008 and were free of therapy.

CD4⁺ or CD8⁺ cells were evaluated by immunofluorescence with the specific mAbs and FACS analysis; data are expressed as absolute number of positive cells per microliter.

View Large

This Feature Is Available To Subscribers Only